Literature DB >> 33707442

An extended APOBEC3A mutation signature in cancer.

Adam Langenbucher1, Danae Bowen2, Ramin Sakhtemani1,3,4, Elodie Bournique2, Jillian F Wise1,3,5,6, Lee Zou7,8, Ashok S Bhagwat9,10, Rémi Buisson11,12, Michael S Lawrence13,14,15.   

Abstract

APOBEC mutagenesis, a major driver of cancer evolution, is known for targeting TpC sites in DNA. Recently, we showed that APOBEC3A (A3A) targets DNA hairpin loops. Here, we show that DNA secondary structure is in fact an orthogonal influence on A3A substrate optimality and, surprisingly, can override the TpC sequence preference. VpC (non-TpC) sites in optimal hairpins can outperform TpC sites as mutational hotspots. This expanded understanding of APOBEC mutagenesis illuminates the genomic Twin Paradox, a puzzling pattern of closely spaced mutation hotspots in cancer genomes, in which one is a canonical TpC site but the other is a VpC site, and double mutants are seen only in trans, suggesting a two-hit driver event. Our results clarify this paradox, revealing that both hotspots in these twins are optimal A3A substrates. Our findings reshape the notion of a mutation signature, highlighting the additive roles played by DNA sequence and DNA structure.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33707442     DOI: 10.1038/s41467-021-21891-0

Source DB:  PubMed          Journal:  Nat Commun        ISSN: 2041-1723            Impact factor:   14.919


  47 in total

Review 1.  APOBEC3 genes: retroviral restriction factors to cancer drivers.

Authors:  Stephen Henderson; Tim Fenton
Journal:  Trends Mol Med       Date:  2015-03-25       Impact factor: 11.951

Review 2.  [Functional heterogeneity of the limbic structures of the brain in organizing feeding and defensive behaviors].

Authors:  G M Chaĭchenko
Journal:  Usp Fiziol Nauk       Date:  1985 Jan-Mar

3.  Characterizing Mutational Signatures in Human Cancer Cell Lines Reveals Episodic APOBEC Mutagenesis.

Authors:  Mia Petljak; Ludmil B Alexandrov; Jonathan S Brammeld; Stacey Price; David C Wedge; Sebastian Grossmann; Kevin J Dawson; Young Seok Ju; Francesco Iorio; Jose M C Tubio; Ching Chiek Koh; Ilias Georgakopoulos-Soares; Bernardo Rodríguez-Martín; Burçak Otlu; Sarah O'Meara; Adam P Butler; Andrew Menzies; Shriram G Bhosle; Keiran Raine; David R Jones; Jon W Teague; Kathryn Beal; Calli Latimer; Laura O'Neill; Jorge Zamora; Elizabeth Anderson; Nikita Patel; Mark Maddison; Bee Ling Ng; Jennifer Graham; Mathew J Garnett; Ultan McDermott; Serena Nik-Zainal; Peter J Campbell; Michael R Stratton
Journal:  Cell       Date:  2019-03-07       Impact factor: 41.582

4.  APOBEC-mediated cytosine deamination links PIK3CA helical domain mutations to human papillomavirus-driven tumor development.

Authors:  Stephen Henderson; Ankur Chakravarthy; Xiaoping Su; Chris Boshoff; Tim Robert Fenton
Journal:  Cell Rep       Date:  2014-06-05       Impact factor: 9.423

5.  APOBEC3A is a potent inhibitor of adeno-associated virus and retrotransposons.

Authors:  Hui Chen; Caroline E Lilley; Qin Yu; Darwin V Lee; Jody Chou; Iñigo Narvaiza; Nathaniel R Landau; Matthew D Weitzman
Journal:  Curr Biol       Date:  2006-03-07       Impact factor: 10.834

6.  Cytidine deamination of retroviral DNA by diverse APOBEC proteins.

Authors:  Kate N Bishop; Rebecca K Holmes; Ann M Sheehy; Nicholas O Davidson; Soo-Jin Cho; Michael H Malim
Journal:  Curr Biol       Date:  2004-08-10       Impact factor: 10.834

7.  Structural basis for targeted DNA cytosine deamination and mutagenesis by APOBEC3A and APOBEC3B.

Authors:  Ke Shi; Michael A Carpenter; Surajit Banerjee; Nadine M Shaban; Kayo Kurahashi; Daniel J Salamango; Jennifer L McCann; Gabriel J Starrett; Justin V Duffy; Özlem Demir; Rommie E Amaro; Daniel A Harki; Reuben S Harris; Hideki Aihara
Journal:  Nat Struct Mol Biol       Date:  2016-12-19       Impact factor: 15.369

Review 8.  Perspective: APOBEC mutagenesis in drug resistance and immune escape in HIV and cancer evolution.

Authors:  S Venkatesan; R Rosenthal; N Kanu; N McGranahan; J Bartek; S A Quezada; J Hare; R S Harris; C Swanton
Journal:  Ann Oncol       Date:  2018-03-01       Impact factor: 32.976

9.  APOBEC3A is a prominent cytidine deaminase in breast cancer.

Authors:  Luis M Cortez; Amber L Brown; Madeline A Dennis; Christopher D Collins; Alexander J Brown; Debra Mitchell; Tony M Mertz; Steven A Roberts
Journal:  PLoS Genet       Date:  2019-12-16       Impact factor: 5.917

10.  Signatures of mutational processes in human cancer.

Authors:  Ludmil B Alexandrov; Serena Nik-Zainal; David C Wedge; Samuel A J R Aparicio; Sam Behjati; Andrew V Biankin; Graham R Bignell; Niccolò Bolli; Ake Borg; Anne-Lise Børresen-Dale; Sandrine Boyault; Birgit Burkhardt; Adam P Butler; Carlos Caldas; Helen R Davies; Christine Desmedt; Roland Eils; Jórunn Erla Eyfjörd; John A Foekens; Mel Greaves; Fumie Hosoda; Barbara Hutter; Tomislav Ilicic; Sandrine Imbeaud; Marcin Imielinski; Marcin Imielinsk; Natalie Jäger; David T W Jones; David Jones; Stian Knappskog; Marcel Kool; Sunil R Lakhani; Carlos López-Otín; Sancha Martin; Nikhil C Munshi; Hiromi Nakamura; Paul A Northcott; Marina Pajic; Elli Papaemmanuil; Angelo Paradiso; John V Pearson; Xose S Puente; Keiran Raine; Manasa Ramakrishna; Andrea L Richardson; Julia Richter; Philip Rosenstiel; Matthias Schlesner; Ton N Schumacher; Paul N Span; Jon W Teague; Yasushi Totoki; Andrew N J Tutt; Rafael Valdés-Mas; Marit M van Buuren; Laura van 't Veer; Anne Vincent-Salomon; Nicola Waddell; Lucy R Yates; Jessica Zucman-Rossi; P Andrew Futreal; Ultan McDermott; Peter Lichter; Matthew Meyerson; Sean M Grimmond; Reiner Siebert; Elías Campo; Tatsuhiro Shibata; Stefan M Pfister; Peter J Campbell; Michael R Stratton
Journal:  Nature       Date:  2013-08-14       Impact factor: 49.962

View more
  15 in total

1.  APOBEC3F expression in triple-negative breast cancer is associated with tumor microenvironment infiltration and activation of cancer immunity and improved survival.

Authors:  Rongrong Wu; Masanori Oshi; Mariko Asaoka; Michelle R Huyser; Yoshihisa Tokumaru; Akimitsu Yamada; Li Yan; Itaru Endo; Takashi Ishikawa; Kazuaki Takabe
Journal:  Am J Cancer Res       Date:  2022-02-15       Impact factor: 6.166

Review 2.  Therapeutic and prognostic insights from the analysis of cancer mutational signatures.

Authors:  Samuel W Brady; Alexander M Gout; Jinghui Zhang
Journal:  Trends Genet       Date:  2021-09-02       Impact factor: 11.639

Review 3.  Application of non-negative matrix factorization in oncology: one approach for establishing precision medicine.

Authors:  Ryuji Hamamoto; Ken Takasawa; Hidenori Machino; Kazuma Kobayashi; Satoshi Takahashi; Amina Bolatkan; Norio Shinkai; Akira Sakai; Rina Aoyama; Masayoshi Yamada; Ken Asada; Masaaki Komatsu; Koji Okamoto; Hirokazu Kameoka; Syuzo Kaneko
Journal:  Brief Bioinform       Date:  2022-07-18       Impact factor: 13.994

4.  Enrichment of centromeric DNA from human cells.

Authors:  Riccardo Gamba; Giulia Mazzucco; Therese Wilhelm; Leonid Velikovsky; Catalina Salinas-Luypaert; Florian Chardon; Julien Picotto; Mylène Bohec; Sylvain Baulande; Ylli Doksani; Daniele Fachinetti
Journal:  PLoS Genet       Date:  2022-07-19       Impact factor: 6.020

5.  Human activation-induced deaminase lacks strong replicative strand bias or preference for cytosines in hairpin loops.

Authors:  Ramin Sakhtemani; Madusha L W Perera; Daniel Hübschmann; Reiner Siebert; Michael S Lawrence; Ashok S Bhagwat
Journal:  Nucleic Acids Res       Date:  2022-05-20       Impact factor: 19.160

Review 6.  Physical Forces and Transient Nuclear Envelope Rupture during Metastasis: The Key for Success?

Authors:  Benoit R Gauthier; Petra I Lorenzo; Valentine Comaills
Journal:  Cancers (Basel)       Date:  2021-12-24       Impact factor: 6.639

7.  Association of mutation signature effectuating processes with mutation hotspots in driver genes and non-coding regions.

Authors:  John K L Wong; Christian Aichmüller; Markus Schulze; Mario Hlevnjak; Shaymaa Elgaafary; Peter Lichter; Marc Zapatka
Journal:  Nat Commun       Date:  2022-01-10       Impact factor: 14.919

Review 8.  Examination of the APOBEC3 Barrier to Cross Species Transmission of Primate Lentiviruses.

Authors:  Amit Gaba; Ben Flath; Linda Chelico
Journal:  Viruses       Date:  2021-06-07       Impact factor: 5.048

9.  Prospectively defined patterns of APOBEC3A mutagenesis are prevalent in human cancers.

Authors:  Rachel A DeWeerd; Eszter Németh; Ádám Póti; Nataliya Petryk; Chun-Long Chen; Olivier Hyrien; Dávid Szüts; Abby M Green
Journal:  Cell Rep       Date:  2022-03-22       Impact factor: 9.995

10.  Primary Founder Mutations in the PRKDC Gene Increase Tumor Mutation Load in Colorectal Cancer.

Authors:  Hajnalka Laura Pálinkás; Lőrinc Pongor; Máté Balajti; Ádám Nagy; Kinga Nagy; Angéla Békési; Giampaolo Bianchini; Beáta G Vértessy; Balázs Győrffy
Journal:  Int J Mol Sci       Date:  2022-01-06       Impact factor: 5.923

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.